Brian Drachman, MD
Cardiovascular Disease · Philadelphia, PANPI 1801827597
Payments from drug & device makers
Across 403 payments — averaging $9427.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alnylam Pharmaceuticals Inc.$3.1M
- Pfizer$451K
- AstraZeneca$209K
- Ionis Pharmaceuticals, Inc.$29K
- Eidos Therapeutics, Inc.$29K
- Akcea Therapeutics, Inc.$500
- plus $59 from 3 others
Across 23 payments — averaging $1494.35 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$34K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 313 | $3,080,522 |
| Pfizer | 54 | $451,387 |
| AstraZeneca(2 entities) | 16 | $208,711 |
| Ionis Pharmaceuticals, Inc. | 9 | $29,345 |
| Eidos Therapeutics, Inc. | 7 | $28,953 |
| Akcea Therapeutics, Inc. | 1 | $500 |
| Impulse Dynamics (USA) Inc. | 1 | $25 |
| Cardiva Medical, Inc. | 1 | $22 |
| E.r. Squibb & Sons, L.L.C. | 1 | $12 |
How this compares
$3,799,477 in reported general payments places this provider in the 95th percentile of 1,250 cardiovascular disease providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Philadelphia
- Danielle DuffyPhiladelphia$29.5M
- Bonnie KyPhiladelphia$1.9M
- Marielle Scherrer CrosbiePhiladelphia$1.6M
- Paul ForfiaPhiladelphia$1.2M
- Quang BuiPhiladelphia$933K
- Leandro Slipczuk BustamantePhiladelphia$638K
- William MatthaiPhiladelphia$542K
- Dean KaralisPhiladelphia$463K
- Nehal MehtaPhiladelphia$419K
- Sharlene DayPhiladelphia$343K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.